Patent: 9,271,961
✉ Email this page to a colleague
Summary for Patent: 9,271,961
Title: | Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof |
Abstract: | The invention includes compositions comprising selective AKR1C3 inhibitors. The invention also includes compositions comprising bifunctional AKR1C3 inhibitors and selective androgen receptor modulators. The invention further includes methods of treatment using the compositions of the invention. |
Inventor(s): | Penning; Trevor M. (Springfield, PA), Adeniji; Adegoke O. (Drexel Hill, PA), Burns; Michael C. (Philadelphia, PA), Winkler; Jeffrey (Wynnewood, PA), Twenter; Barry (Philadelphia, PA) |
Assignee: | The Trustees of the University of Pennsylvania (Philadelphia, PA) |
Application Number: | 14/050,937 |
Patent Claims: | see list of patent claims |
Details for Patent 9,271,961
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2031-04-13 |
Dendreon Pharmaceuticals Llc | PROVENGE | sipuleucel-t | Injection | 125197 | 04/29/2010 | ⤷ Try a Trial | 2031-04-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |